Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,977 public trials 2,028 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Not Yet Recruiting

Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell Lymphoma

NCT07615283

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

View Trial Details

Not Yet Recruiting

A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement

NCT07615270

Conditions: AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Not Yet Recruiting

Identification of the Best Treatment Pathway for Patients With Relapsed/Refractory Lymphocytic B-derived Non-Hodgkin Lymphoma

NCT07614035

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: IRCCS Policlinico di Sant'Orsola Bologna, Emilia-Romagna, Italy

View Trial Details

Not Yet Recruiting

Phase I Study of FXS0683 in the Treatment of Blood Tumors

NCT07616089

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, B-cell Lymphoma, +18 more
Locations: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS) Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

Study to Evaluate the Safety of UF-KURE-BCMA CAR T-Cells in Advanced Myeloma

NCT07611149

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

U96-CAR-T-Cells For R/R B-ALL

NCT07511426

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)

NCT07609940

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Cytokine Release Syndrome, +19 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of the Combination of Belantamab Mafodotin, Bortezomib, and Dexamethasone (BVd) in Participants With Multiple Myeloma and Moderate Hepatic Impairment

NCT07609706

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Pomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma

NCT07609446

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

FLASH Pilot Phase 1 Safety Study

NCT07608549

Conditions: Cutaneous Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions